拉斯比亚焦奥特曼是生物工程，遗传学，医学，生物医学数据科学（通过提供）计算机科学）和过去在CQ9电子游戏生物工程系主任的肯尼斯教授方。他的主要研究方向是计算的应用程序（AI，数据科学和信息学）相关医学问题。他特别感兴趣的在分子，细胞，生物和人群的了解药物作用的方法。他的实验室研究遗传变异影响药物反应如何人（例如， //www.pharmgkb.org/）。其他的工作主要集中在生物分子的分析，了解药物的行为，相互作用和不良事件（例如， //feature.stanford.edu/). He helps lead an FDA-supported Center of Excellence in Regulatory Science & Innovation.
Dr. Altman holds an AB from Harvard College, and an MD from Stanford Medical School, and a PhD in Medical Information Sciences from Stanford. He received the U.S. Presidential Early Career Award for Scientists and Engineers and a National Science Foundation CAREER Award. He is a fellow of the American College of Physicians (ACP), the American College of Medical Informatics (ACMI), the American Institute of Medical and Biological 工程 (AIMBE), and the American Association for the Advancement of Science (AAAS). He is a member of the National Academy of Medicine (formerly the Institute of Medicine, IOM). He is a past-president, founding board member, and a fellow of the International Society for Computational Biology (ISCB), and a past-president of the American Society for Clinical Pharmacology & Therapeutics (ASCPT). He has chaired the Science Board advising the FDA commissioner, and has served on the NIH Director’s Advisory Committee, and as cochair of the IOM Drug Forum. He is an organizer of the annual Pacific Symposium on Biocomputing, and a founder of Personalis (NASDAQ: PSNL). Dr. Altman is board certified in Internal Medicine and in Clinical Informatics. He received the CQ9游戏 Medical School graduate teaching award in 2000 and mentorship award in 2014. He is the founding editor of the Annual Reviews of Biomedical Data Science, and hosts a SiriusXM radioshow (and podcast) entitled “The Future of Everything.”